News Release

BASEL, SWITZERLAND – Medartis Holding AG recently announced that it has completed the acquisition of Nextremity Solutions Inc., a strategic commercialization organization located in Warsaw.

Rod K. Mayer

The total purchase price for the transaction will be up to $70 million and includes milestone and earn-out payments of up to $30 million.

This acquisition, which was announced March 7, 2022, will enable Medartis to further accelerate its US extremities business by gaining access to a comprehensive product pipeline, strong relationships to US design surgeons and an experienced R&D team.

This transaction will provide significant growth opportunities in the US extremities market and potentially elsewhere. Medartis also acquires a modern regional manufacturing base and a complementary leadership organization.

The acquisition of Nextremity Solutions Inc. was consolidated as of May 3, 2022. The first products with significant sales potential are expected to be launched in early 2023 and will therefore not have a material impact on the company’s sales guidance in 2022.

To maximize the business impact, the two organizations became synergistically merged as of May 3.

As part of this merger, NSI’s CEO Rod K. Mayer is appointed president of Medartis US as a non-executive member. Rod is a highly-experienced industry expert with a long and distinguished track record in sales and product development in the medical devices industry. In his role, he will report directly to CEO Christoph Brönnimann and lead Medartis’ US organization, focusing specifically on leading the US sales force.

Medartis will continue to base its local organization in Exton, Pennsylvania, and Warsaw, in accordance with the functional area, while product development and manufacturing will be located at NSI’s former headquarters. “I am honored and excited to lead the combined Medartis US team. We intend to build on our shared vision and common culture to deliver meaningful innovation for our customers. I believe this is an impactful combination that will support an attractive growth trajectory in the future,” commented Mayer.

Lisa C. Thompson, president North America, has decided to resign following the successful reorganization of the US business and the acquisition of NSI. She will support Rod K. Mayer during the transition phase and plans to resume her consulting activities in the medical device industry. CEO Christoph Brönnimann commented, “I am delighted that Rod K. Mayer and the rest of NSI’s leadership team are complementing our US organization. I would like to express my gratitude to Lisa for her dedication and commitment to this company. Lisa has repositioned our US organization over the past two years, shaping it into a sustainable, competitive and customer-centric sales organization. I wish her the very best in her future endeavors.”

Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures for upper and lower extremities as well as for the craniomaxillofacial region. Medartis employs approximately 700 individuals across its 14 locations, with products offered in over 50 countries globally. For more information, visit www.medartis.com.

Nextremity Solutions Inc. is a privately held strategic commercialization organization with a focus on lower and upper extremity, trauma, sports medicine and joint preservation, offering innovative solutions and Revenue Ready products for various extremity musculoskeletal applications. The company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes. For more information, please visit www.nextremity.com.